los angeles semaglutide vs Tirzepatide explained simply 👇 Both medications are used in medical weight loss and both can support appetite control, blood sugar regulation, and sustainable fat loss. But they do not work Golden Afternoon | GLP-1 Weight

Long-term cardiovascular evidence for orforglipron is still accumulating

Clinical data showed A1C reduction of 2.02% in diabetic participants, triglyceride reduction of 28%, systolic blood pressure reduction of 6.8 mmHg, LDL cholesterol reduction of 12%, and liver fat reduction of 44% measured by MRI

as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with established cardiovascular disease, with a BMI 27 kg/m 2 , and without established Type 1 or Type 2 diabetes

With direct delivery into the bloodstream, this method ensures optimal effectiveness, making it a popular choice for both aesthetic enhancement and overall health support

KPV and thymosin alpha-1 are commonly discussed alternatives, but all share the same evidence and regulatory limits